Article
The 894 G > T variant of endothelial nitric oxide synthase (eNOS) increases the risk of recurrent venous thrombosis through interaction with elevated homocysteine levels.
Journal of thrombosis and haemostasis : JTH - 1 May 2004
Heil S G, Den Heijer M, Van Der Rijt-Pisa B J M, Kluijtmans L A J, Blom H J
Abstract excerpt
BACKGROUND: Venous thrombosis is a multicausal disease involving both genetic as well as acquired risk factors. Hyperhomocysteinemia is associated with a 2-fold increased risk of recurrent venous thrombosis (RVT). Recently, the 894 G > T variant of endothelial nitric oxide synthase (eNOS) was pos...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.